header
Image from OpenLibrary

Evaluation of radio - chemotherapy in post - operative high risk head and neck cancer / Mohamed Mahmoud Abdelhakim ; Supervised Hassan Kamel Awwad , Samy Ahmed Eibadawy , Heba Elzawahry

By: Contributor(s): Language: Eng Publication details: Cairo : Mohamed Mahmoud Abdelhakim , 2008Description: 193P. : charts , facsimiles ; 25cmOther title:
  • دراسة تقييم العلاج الاشعاعى والكيمائى فى الحالات المتقدمة لأورام الرأس والرقبة فيما بعد الجراحة [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department Of Oncology Radiation and Radiotherapy Summary: To compare between post - operative concomitant boost radiotherapy with chemotherapy with postoperative concomitant boost radiotherapy and to compare between accelerated hyperfractionation radiotherapy regimen 50.4 Gy given over 11 days , with a concomitant boost 60.2 regimen givenover 5 weeks in the postoperative treatment of high risk head and neck cancer patients
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.06.Ph.D.2008.Mo.E (Browse shelf(Opens below)) Not for loan 01010110049939000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.06.Ph.D.2008.Mo.E (Browse shelf(Opens below)) 49939.CD Not for loan 01020110049939000

Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department Of Oncology Radiation and Radiotherapy

To compare between post - operative concomitant boost radiotherapy with chemotherapy with postoperative concomitant boost radiotherapy and to compare between accelerated hyperfractionation radiotherapy regimen 50.4 Gy given over 11 days , with a concomitant boost 60.2 regimen givenover 5 weeks in the postoperative treatment of high risk head and neck cancer patients

Issued also as CD

There are no comments on this title.

to post a comment.